The USFDA has approved tirzepatide under the brand name Mounjaro, which has become a revolutionary agent for the management and treatment of T2D and achieving weight loss [29,59,60]
GLP-1 receptor agonists, including exenatide, liraglutide, tirzepatide and semaglutide, mimic the action of GLP-1 and have been approved by the Food and Drug Administration to treat Type 2 diabetes and obesity
In this regard, early exercise at low intensity in the beginning of TBI onset can improve behavioral performance without inducing cognitive deficits, while high-intensity exercise can affect cognitive function [10]
Two people can lose the same number of pounds and see very different changes in their body
Wang, Journal of Luminescence 190, (2017) 115122
L-carnitine cannot overcome a poor diet and a sedentary lifestyle